ArticleThyroid research2025
A new Tec family-based clinical model predicts survival in differentiated thyroid cancer patients via machine learning.
Article in Thyroid research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe Tec family of proteins has been identified as a key player in numerous diseases. However, no studies on the associations of Tec family proteins with overall survival (OS) in differentiated thyroid cancer (DTC) patients have been conducted.
methodsRNA sequencing (RNA-Seq) and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. LASSO-Cox, random forest, and eXtreme Gradient Boosting (XGBoost) analysis methods were used to screen for the genes encoding Tec family proteins that were most closely associated with DTC. A predictive model was developed to estimate the OS of DTC patients. The validity of the prediction model was evaluated via receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and fivefold and 200-fold cross-validation. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to investigate the biological functions of the most significant genes.
resultsThe AC007494.3 and AC019226.2 genes were most strongly associated with the OS of DTC patients. Therefore, the model can be used to predict the OS of DTC patients. Functional annotation analysis revealed characteristics similar to those of other Tec kinases.
conclusionsWe found that the TEC gene has significant predictive value for the prognosis of DTC patients. The TEC gene has potential value as a target for future drug development. In addition, we recommend more comprehensive treatment and closer monitoring of high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.